Sutro Biopharma STRO Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's income tax?
- Sutro Biopharma (STRO) reported income tax of -$15K in Q1 2026.
- How has Sutro Biopharma's income tax changed year-over-year?
- Sutro Biopharma's income tax decreased by 314.3% year-over-year, from $7K to -$15K.
- What is the long-term trend for Sutro Biopharma's income tax?
- Over 2 years (2023 to 2025), Sutro Biopharma's income tax has grown at a -92.9% compound annual growth rate (CAGR), from $18.19M to -$93K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.